Surgical Science Sweden is forecast to grow earnings and revenue by 28.4% and 10.2% per annum respectively. EPS is expected to grow by 28.4% per annum. Return on equity is forecast to be 4.2% in 3 years.
Key information
28.4%
Earnings growth rate
28.43%
EPS growth rate
Medical Equipment earnings growth
17.1%
Revenue growth rate
10.2%
Future return on equity
4.16%
Analyst coverage
Low
Last updated
10 Jun 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
OTCPK:SUSR.F - Analysts future estimates and past financials data (SEK Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
1,240
173
175
220
4
12/31/2027
1,115
138
134
172
4
12/31/2026
1,003
100
133
140
3
3/31/2026
977
52
93
150
N/A
12/31/2025
992
67
30
80
N/A
9/30/2025
975
70
17
64
N/A
6/30/2025
943
92
42
90
N/A
3/31/2025
947
141
56
104
N/A
12/31/2024
884
132
90
137
N/A
9/30/2024
860
193
73
120
N/A
6/30/2024
838
198
100
151
N/A
3/31/2024
842
208
159
206
N/A
12/31/2023
883
234
194
238
N/A
9/30/2023
906
253
231
277
N/A
6/30/2023
901
234
194
234
N/A
3/31/2023
872
221
140
179
N/A
12/31/2022
803
188
95
129
N/A
9/30/2022
750
138
11
38
N/A
6/30/2022
640
124
61
80
N/A
3/31/2022
489
101
45
59
N/A
12/31/2021
367
86
25
39
N/A
9/30/2021
209
30
59
69
N/A
6/30/2021
138
21
17
26
N/A
3/31/2021
122
18
11
20
N/A
12/31/2020
105
16
15
23
N/A
9/30/2020
104
14
4
14
N/A
6/30/2020
112
19
42
54
N/A
3/31/2020
107
17
37
47
N/A
12/31/2019
102
13
N/A
55
N/A
9/30/2019
88
6
N/A
56
N/A
6/30/2019
70
-5
N/A
12
N/A
3/31/2019
68
-5
N/A
9
N/A
12/31/2018
66
-5
N/A
7
N/A
9/30/2018
60
-3
N/A
9
N/A
6/30/2018
57
-6
N/A
0
N/A
3/31/2018
56
-7
N/A
8
N/A
12/31/2017
57
-3
N/A
7
N/A
9/30/2017
65
4
N/A
6
N/A
6/30/2017
60
3
N/A
12
N/A
3/31/2017
59
4
N/A
11
N/A
12/31/2016
58
3
N/A
13
N/A
12/31/2015
52
2
N/A
8
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SUSR.F's forecast earnings growth (28.4% per year) is above the savings rate (3.5%).
Earnings vs Market: SUSR.F's earnings (28.4% per year) are forecast to grow faster than the US market (17.8% per year).
High Growth Earnings: SUSR.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SUSR.F's revenue (10.2% per year) is forecast to grow slower than the US market (12.8% per year).
High Growth Revenue: SUSR.F's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SUSR.F's Return on Equity is forecast to be low in 3 years time (4.2%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/23 01:49
End of Day Share Price
2026/05/22 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Surgical Science Sweden AB (publ) is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.